Dopamine inhibitory and excitatory systems in tardive dyskinesias.
D000818:Animals; D001058:Apomorphine / Q000037:antagonists & inhibitors; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical / Q000379:methods; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy*; D006892:Hydroxydopamines / Q000494:pharmacology; D008297:Male; D009714:Nucleus Accumbens / Q000187:drug effects; D016627:Oxidopamine; D010891:Piribedil; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000187:drug effects; D013469:Sulpiride / Q000627:therapeutic use
D006892:Hydroxydopamines; D011954:Receptors, Dopamine; D013469:Sulpiride; D016627:Oxidopamine; D010891:Piribedil; D001058:Apomorphine